Aehr's revenue rebounded from $9.9M in 2026Q2 to $33.0M in 2027Q1 and gross margin recovered from 25.7% to 47.5%, suggesting volume leverage on fixed manufacturing costs is beginning to work.
Price trend, volume and key moving averages
Trailing total returns as of 11/8/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC).
Check whether operating performance supports the current valuation.
Recent results and news deserve attention only when they alter the forward view.
| Quarter | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|
Q4 2026Latest Nov 2, 2026 | $0.22+100.0% vs $0.11 | $33M+19.9% vs $28M |
Q3 2026 Jul 14, 2026 | $0.11+1200.0% vs -$0.01 | $19M+0.6% vs $19M |
Q2 2026 Apr 7, 2026 | -$0.05+28.6% vs -$0.07 | $10M-5.0% vs $11M |
Q1 2026 Jan 8, 2026 | -$0.04+50.0% vs -$0.08 | $10M-14.5% vs $12M |
Aehr Test Systems (NASDAQ: AEHR - Get Free Report) was the target of unusually large options trading activity on Tuesday. Traders purchased 14,866 call options on the stock. This represents an increase of approximately 51% compared to the average volume of 9,837 call options. Aehr Test Systems Trading Down 6.6% Shares of NASDAQ: AEHR opened at $60.84
Aehr Test Systems' Q1 results surge on AI semiconductor demand, stronger margins and rising backlog.
Aehr Test Systems raised its fiscal 2027 revenue guidance to $150 million. Effective backlog reached $109.3 million as of November 1.
Shares of Aehr Test Systems (NASDAQ:AEHR) rose sharply in pre-market trading after the company reported better-than-expected first-quarter financial results and raised its FY27 sales guidance above estimates.
Benchmark AEHR against direct peers instead of judging its metrics in isolation.
Key metrics vs top competitors for Aehr Test Systems (AEHR)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $53.57 | $1.68B | 839.66 | -15.21% | 2.93% | 1.2% | — | |
| $38.49 | $1.82B | -92.66 | 12.74% | -3.97% | -2.9% | — | |
| $99.24 | $3.05B | 29.52 | -17.57% | 11.75% | 9.82% | — | |
| $173.28 | $8.62B | 64.92 | 1.82% | 11.84% | 6.5% | — | |
| $30.97 | $1.08B | 336.26 | 11.61% | 0.32% | 0.46% | — | |
| $81.12 | $6.32B | 37.12 | 2.8% | 17.72% | 15.83% | — |
Aehr Test Systems (AEHR) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Verify the primary filings, follow material updates, and answer the remaining questions.
Aehr Test Systems (AEHR) SEC filings — annual & quarterly reports (10-K, 10-Q)
Nov 2, 2026·SEC
Oct 29, 2026·SEC
Oct 20, 2026·SEC
Jul 28, 2025·SEC
Get notified when AEHR posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
Aehr Test Systems (AEHR) stock FAQ — growth, dividends, profitability & financials explained
Aehr Test Systems (AEHR) reported $73.0M in revenue over the trailing twelve months. Revenue was $50.0M in fiscal year 2026. That is 19% more than the $42.0M of fiscal year 1997.
Aehr Test Systems (AEHR) grew revenue by 28.4% over the trailing twelve months, compared with the twelve months before.
Yes. Aehr Test Systems (AEHR) earned $2.1M in net income over the trailing twelve months (a 2.9% net margin).
Aehr Test Systems (AEHR) had a return on equity (ROE) of 1.2% over the trailing twelve months. That is below the market's typical 10-15%.
Aehr Test Systems (AEHR) had negative free cash flow of $6.8M over the trailing twelve months.
